Ardsley Advisory Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-100,000
| Closed | -$5.48M | – | 93 |
|
|
2022
Q3 | $5.48M | Sell |
100,000
-66,000
| -40% | -$3.62M | 1.23% | 24 |
|
|
2022
Q2 | $11M | Sell |
166,000
-15,000
| -8% | -$991K | 1.8% | 9 |
|
|
2022
Q1 | $12M | Buy |
181,000
+180,350
| +27,746% | +$12M | 2% | 10 |
|
|
2021
Q4 | $38K | Sell |
650
-300,050
| -100% | -$17.5M | 0.01% | 81 |
|
|
2021
Q3 | $18.1M | Buy |
300,700
+150,700
| +100% | +$9.05M | 2.75% | 5 |
|
|
2021
Q2 | $8.99M | Buy |
+150,000
| New | +$8.99M | 1.06% | 21 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 97 |
|
|
2020
Q4 | – | Sell |
-9,500
| Closed | -$521K | – | 111 |
|
|
2020
Q3 | $521K | Sell |
9,500
-5,000
| -34% | -$274K | 0.1% | 79 |
|
|
2020
Q2 | $767K | Buy |
+14,500
| New | +$767K | 0.16% | 60 |
|
|
2020
Q1 | – | Sell |
-7,500
| Closed | -$374K | – | 97 |
|
|
2019
Q4 | $374K | Buy |
+7,500
| New | +$374K | 0.06% | 93 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 122 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 132 |
|